Literature DB >> 3219513

Age, and size and grade of tumour predict prognosis in incidentally diagnosed carcinoma of the prostate.

C M Goodman1, A Busuttil, G D Chisholm.   

Abstract

Of 403 consecutive cases of prostatic carcinoma 69 were diagnosed incidentally and were managed with a deferred treatment policy. The mean age at diagnosis was 74 years and mean follow-up was 42 months. Retrospective analysis confirmed that many such patients die of intercurrent disease before symptomatic tumour progression. However, patients aged 70 years or less at diagnosis with diffuse, high grade disease were shown to be at greater risk of symptomatic tumour progression. In this study 60% progressed to skeletal metastases within 3 years. Deferral of treatment in such patients appears inappropriate.

Entities:  

Mesh:

Year:  1988        PMID: 3219513     DOI: 10.1111/j.1464-410x.1988.tb04429.x

Source DB:  PubMed          Journal:  Br J Urol        ISSN: 0007-1331


  7 in total

1.  Prognostic variables in patients with prostate cancer: influence of blood group ABO (H), the Rhesus system, age, differentiation, tumour stage and metastases.

Authors:  E Kvist; J Krogh; P Hjortberg
Journal:  Int Urol Nephrol       Date:  1992       Impact factor: 2.370

2.  Screening for carcinoma of the prostate by digital rectal examination in a randomly selected population.

Authors:  K V Pedersen; P Carlsson; E Varenhorst; O Löfman; K Berglund
Journal:  BMJ       Date:  1990-04-21

Review 3.  Prostate cancer: 2. Natural history.

Authors:  R K Nam; M A Jewett; M D Krahn
Journal:  CMAJ       Date:  1998-09-22       Impact factor: 8.262

Review 4.  Prevention. How much harm? How much benefit? 2. Ten potential pitfalls in determining the clinical significance of benefits.

Authors:  K G Marshall
Journal:  CMAJ       Date:  1996-06-15       Impact factor: 8.262

5.  A tribute to professor Geoffrey D Chisholm CBE ChM PPRCS Ed FRCS Eng FRCP Ed FRCPSG FRACS (Hon) FCSSA (Hon) FACS (Hon) FRSE.

Authors:  G Williams
Journal:  J R Soc Med       Date:  1996       Impact factor: 5.344

6.  Attitude of African-Americans regarding prostate cancer clinical trials.

Authors:  S B Robinson; M Ashley; M A Haynes
Journal:  J Community Health       Date:  1996-04

7.  Measures of mortality in prostatic cancer.

Authors:  C M Goodman; A W Ritchie; G D Chisholm
Journal:  Br J Cancer       Date:  1990-03       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.